<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two hundred consecutive patients who were referred for evaluation of spontaneous or <z:hpo ids='HP_0004419'>recurrent thrombosis</z:hpo> were investigated for possible <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable states</z:e> to determine the relative frequencies of these conditions in the Australian population and to identify features that would indicate which patients should be investigated with the expensive battery of tests for <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable states</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Thirty-two percent were found to have prolongation of the postvenous occlusion euglobulin clot lysis time (<z:chebi fb="11" ids="53703">PVO</z:chebi>-ELT), 32% were found to have elevated levels of plasminogen activator inhibitor-1 (PAI) and 66% were found to have reduced release of tissue plasminogen activator (tPA) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> were found in 12% </plain></SENT>
<SENT sid="3" pm="."><plain>Hereditary <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> was found in 2% </plain></SENT>
<SENT sid="4" pm="."><plain>Hereditary deficiency of the naturally-occurring anti-coagulant factors protein C and protein S was found in 2% </plain></SENT>
<SENT sid="5" pm="."><plain>Age, sex, site of <z:mp ids='MP_0005048'>thrombosis</z:mp> (venous or arterial), or presence of a family history was not helpful in predicting a group more likely to have abnormal investigation results </plain></SENT>
<SENT sid="6" pm="."><plain>Reduced fibrinolytic activity and the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> are the most common findings in patients with <z:hpo ids='HP_0001907'>thromboembolic disease</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Further prospective studies are required to assess the natural history and appropriate management of patients with these abnormalities </plain></SENT>
</text></document>